Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Camel whey protein (CWP) is a bioactive protein fraction derived from camel milk, characterized by its high concentrations of antimicrobial and antioxidant proteins such as lactoferrin, lactoperoxidase, and lysozyme. Unlike bovine whey, it lacks beta-lactoglobulin, making it a potentially hypoallergenic alternative. CWP is recognized for its potent antioxidant, anti-inflammatory, and immunomodulatory properties, which are largely mediated through the activation of the Nrf2/HO-1 signaling pathway and the suppression of pro-inflammatory cascades involving NF-kappaB and the NLRP3 inflammasome. It has been investigated for various therapeutic applications, including the treatment of periodontitis, recurrent aphthous ulcers, wound healing, and protection against organ toxicity induced by heavy metals, drugs, or heat stress. It is also utilized in the form of enzymatic hydrolysates (peptides) to enhance its bioavailability and specific biological activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on camel whey protein.